Chemistry before commerce

Alkaloids on Amazon

A science-first directory for understanding naturally occurring alkaloids that appear in online supplement conversations—without pretending a marketplace listing proves identity, evidence, safety, or quality.

Commerce status: research only

This page has no affiliate links, merchant links, ranked products, prices, or verified availability claims. Product recommendations remain intentionally inactive until a current catalog, label, testing, manufacturer, claims, disclosure, legal, privacy, and tracking review is complete.

Read the site’s affiliate and editorial policy

1 · Identity

The name is not enough

“Poppy,” “lotus,” and “cat’s claw” can each hide a species problem. Start with the Latin binomial and plant part before considering evidence.

2 · Evidence

Separate the evidence lanes

Human outcomes, traditional use, receptor mechanisms, and animal studies answer different questions. This directory never treats them as interchangeable.

3 · Product

A listing is not verification

FDA does not approve dietary supplements for safety and effectiveness before sale. Labels, testing, claims, and manufacturers require their own review. [2, 3]

Ingredient directory

Compare the chemistry before the catalog

Evidence labels describe the kind of research available—not a recommendation. Higher-caution entries stay visible because hiding risk would make this directory less useful.

Filter the directory

Showing 10 of 10 entries.

Caffeine

Caffeine from coffee, tea, guarana, kola nut, or yerba maté—or isolated caffeine

Dose and stacking matter
Named alkaloid(s)
Caffeine
Chemical class
Methylxanthine (purine alkaloid)
Evidence signal
Substantial human evidence
Safety read: Check the total caffeine from every source. Extra caution is warranted with anxiety, sleep disruption, pregnancy, cardiovascular sensitivity, and other stimulants.
Evidence by source type

Human: Acute alertness and performance effects are well studied in people. Evidence for weight loss or broad “metabolism” promises is much less useful and often comes from multi-ingredient products.

Traditional context: Caffeinated plants have long food and beverage histories, but that does not make concentrated extracts equivalent to tea or coffee.

Mechanistic/preclinical: Adenosine-receptor antagonism explains stimulation; tolerance, sleep timing, total daily exposure, and stimulant stacking shape the practical risk.

What the label must make clear

  • Exact caffeine amount per serving
  • All botanical caffeine sources disclosed
  • No stimulant blend hiding the total dose

Berberine

An isolated constituent found in barberry, goldenseal, Oregon grape, and related plants

Interaction caution
Named alkaloid(s)
Berberine
Chemical class
Isoquinoline alkaloid
Evidence signal
Human evidence, interaction-heavy
Safety read: Medication review is important. Avoid during pregnancy, breastfeeding, and infancy; gastrointestinal effects are common in clinical use.
Evidence by source type

Human: Human trials and reviews report changes in some glucose and lipid markers, but study quality and populations vary. This is not evidence that berberine replaces prescribed treatment.

Traditional context: Berberine-containing plants have histories in several medical traditions; modern isolated products are a different exposure from traditional preparations.

Mechanistic/preclinical: Multiple metabolic enzymes, transporters, and signaling pathways have been studied. The same breadth helps explain why medication interactions deserve prominent attention.

What the label must make clear

  • Chemical form stated clearly
  • Amount per serving is visible
  • No “natural GLP-1” or medication-replacement positioning

Theobromine

A constituent of cacao; also used as an isolated ingredient in some formulas

Concentration matters
Named alkaloid(s)
Theobromine
Chemical class
Methylxanthine (purine alkaloid)
Evidence signal
Limited use-specific human evidence
Safety read: Concentrated products should not be treated like ordinary chocolate. Check for added caffeine and consider cardiovascular or sleep sensitivity.
Evidence by source type

Human: Human exposure through cacao is familiar, but that does not establish a benefit for concentrated standalone products or multi-ingredient “energy” formulas.

Traditional context: Cacao has a long food and ceremonial history. Historical use should not be used as a dose or efficacy claim for extracts.

Mechanistic/preclinical: Theobromine is pharmacologically related to caffeine but has a different stimulant and cardiovascular profile.

What the label must make clear

  • Theobromine amount stated
  • Added caffeine separated from the total
  • No proprietary “energy matrix”

California poppy

Eschscholzia californica aerial parts—not Papaver somniferum

Sedative-interaction caution
Named alkaloid(s)
Protopine and related isoquinoline alkaloids
Chemical class
Botanical source of isoquinoline alkaloids
Evidence signal
Traditional use; limited clinical evidence
Safety read: Do not confuse this plant with opium poppy. Avoid stacking sedating botanicals with alcohol, sleep medicines, or other central nervous system depressants without clinical guidance.
Evidence by source type

Human: Clinical evidence is too limited to make confident sleep, anxiety, pain, or withdrawal claims.

Traditional context: European herbal assessments recognize a history of traditional use, which is not the same as strong clinical proof.

Mechanistic/preclinical: Alkaloid and sedative-pathway findings are largely preclinical and do not establish an opioid-like effect in people.

What the label must make clear

  • Botanical name: Eschscholzia californica
  • Aerial plant part identified
  • No “herbal opioid” or withdrawal positioning

Blue lotus

Nymphaea caerulea—not sacred lotus (Nelumbo nucifera)

Higher caution
Named alkaloid(s)
Nuciferine and related aporphine alkaloids
Chemical class
Aporphine alkaloids in a botanical product
Evidence signal
Mostly traditional, chemical, and case-report evidence
Safety read: Sedation and perceptual disturbances have been reported. Reject vaping, smoking, “legal high,” extreme-extract, or kratom/7-OH substitution positioning.
Evidence by source type

Human: There are no robust human trials supporting general wellness, sleep, or withdrawal uses. Published clinical literature includes a small toxicity case series rather than efficacy evidence.

Traditional context: Historical and ritual associations are often repeated online, but they do not establish modern product identity, dose, or clinical benefit.

Mechanistic/preclinical: Receptor findings and constituent chemistry are hypothesis-generating; they do not predict a reliable effect from an unverified extract.

What the label must make clear

  • Botanical name: Nymphaea caerulea
  • Plant part and extraction ratio disclosed
  • Identity and contaminant COA available

Huperzine A

An isolated Lycopodium alkaloid associated with Huperzia serrata

Higher caution
Named alkaloid(s)
Huperzine A
Chemical class
Lycopodium alkaloid; acetylcholinesterase inhibitor
Evidence signal
Clinical-context evidence; uncertain general use
Safety read: Avoid self-directed stacking with other cholinergic ingredients or medicines. Pregnancy, heart-rate concerns, and medication use call for clinician review.
Evidence by source type

Human: Trials and reviews mostly concern dementia-related clinical contexts. Reviews flag heterogeneous, low-quality primary studies, so they do not support casual memory-enhancement claims for healthy shoppers.

Traditional context: Traditional plant use does not map cleanly onto a measured isolated compound.

Mechanistic/preclinical: Acetylcholinesterase inhibition is pharmacologically meaningful and makes cholinergic stacking a safety issue, not a reason to assume cognitive benefit.

What the label must make clear

  • Huperzine A amount shown in micrograms
  • No hidden cholinergic blend
  • No disease-treatment or “limitless” claims

Bitter orange

Citrus aurantium fruit or extract

Higher caution
Named alkaloid(s)
p-Synephrine and related protoalkaloids
Chemical class
Protoalkaloid / sympathomimetic amine (classification varies)
Evidence signal
Small, confounded human studies
Safety read: Reject stimulant stacks, especially products that obscure caffeine or make rapid weight-loss claims. Cardiovascular conditions and medication use require clinician review.
Evidence by source type

Human: Weight-loss studies are generally small, short, and frequently use multi-ingredient formulas, making benefit and safety difficult to attribute to bitter orange.

Traditional context: Traditional citrus use is not evidence for concentrated stimulant-style extracts.

Mechanistic/preclinical: Adrenergic activity raises practical questions about heart rate, blood pressure, and combination with caffeine or other stimulants.

What the label must make clear

  • Citrus aurantium and plant part identified
  • p-Synephrine amount and standardization visible
  • Total caffeine disclosed

Yohimbe

Pausinystalia yohimbe bark or a yohimbine-standardized extract

Higher caution
Named alkaloid(s)
Yohimbine and related indole alkaloids
Chemical class
Indole alkaloids in a botanical stimulant
Evidence signal
Little supplement efficacy evidence; documented risk
Safety read: Associated risks include blood-pressure problems, arrhythmia, heart attack, and seizures. Avoid sexual-enhancement, rapid-fat-loss, and stimulant-stack positioning.
Evidence by source type

Human: NCCIH reports very little research in people on yohimbe supplements and insufficient evidence for health uses. Product analyses have also found major yohimbine-label variability.

Traditional context: Traditional use does not resolve modern extract potency, adulteration, or medication-interaction concerns.

Mechanistic/preclinical: Adrenergic effects are consistent with anxiety, blood-pressure, heart-rate, and stimulant-stacking concerns.

What the label must make clear

  • Botanical identity and bark stated
  • Yohimbine amount verified independently
  • No proprietary sexual-enhancement blend

Corydalis

Corydalis yanhusuo rhizome; species and plant part are essential

Higher caution
Named alkaloid(s)
Tetrahydropalmatine and related isoquinoline alkaloids
Chemical class
Isoquinoline alkaloids in a traditional botanical
Evidence signal
Traditional and preclinical evidence dominate
Safety read: Reject products without species, rhizome identity, alkaloid testing, and contaminant testing. Avoid sedative stacking and self-treatment positioning.
Evidence by source type

Human: Human evidence is not strong enough for confident pain, sleep, or withdrawal recommendations. A recent product analysis found large alkaloid variability and a possible enriched/adulterated sample.

Traditional context: Corydalis rhizome has traditional use in Chinese medicine; that history does not validate an unidentified powder or unusually concentrated extract.

Mechanistic/preclinical: Dopamine and other receptor findings are preclinical and should not be translated into opioid-substitution or analgesic promises.

What the label must make clear

  • Species: Corydalis yanhusuo
  • Rhizome identified
  • Alkaloid profile and contaminant COA available

Cat’s claw

Uncaria tomentosa or Uncaria guianensis—not similarly named herbs

Interaction caution
Named alkaloid(s)
Pentacyclic and tetracyclic oxindole alkaloids
Chemical class
Oxindole alkaloids in a botanical product
Evidence signal
Very limited high-quality human evidence
Safety read: Use extra caution with autoimmune disease, pregnancy, anticoagulant or antiplatelet drugs, blood-pressure drugs, and surgery.
Evidence by source type

Human: NCCIH finds no conclusive human evidence for a health purpose. There is no reliable human evidence supporting cat’s claw as a kratom or 7-OH withdrawal aid.

Traditional context: Amazonian traditional use is culturally important context, but it is not proof for modern disease, pain, or withdrawal claims.

Mechanistic/preclinical: Immune and inflammatory findings do not establish a clinically meaningful outcome and may matter for autoimmune or medication safety.

What the label must make clear

  • Uncaria species named
  • Bark or root plant part identified
  • No withdrawal, detox, or immune-disease claims

Affiliate-readiness gate

Product-screening criteria

These are inclusion gates, not quality decorations. A future catalog entry should fail closed when identity, dose, testing, manufacturer, or positioning cannot be verified.

  1. 01

    Botanical identity

    Require the full Latin binomial; reject common-name-only labels where plants can be confused.

  2. 02

    Plant part

    Bark, rhizome, aerial parts, leaf, seed, and flower are not interchangeable.

  3. 03

    Standardization

    The named marker, percentage, and actual amount per serving should all be visible.

  4. 04

    Supplement Facts

    Every active ingredient and amount should be readable before purchase.

  5. 05

    Responsible manufacturer

    Look for a traceable company, lot number, contact path, and manufacturing-quality information.

  6. 06

    COA and testing

    Prefer lot-specific identity, potency, heavy-metal, microbial, and adulterant testing from an independent laboratory.

  7. 07

    No opaque blends

    Reject proprietary blends that hide the amount of the alkaloid source or accompanying stimulants and sedatives.

  8. 08

    No high-risk positioning

    Reject vaping, smoking, “legal high,” detox, withdrawal-substitute, rapid-weight-loss, or drug-like marketing.

Also check FDA’s current health-fraud notifications, especially for sexual enhancement, weight loss, energy, pain, bodybuilding, and sleep products, where hidden ingredients are a documented concern. [14, 15]

Taxonomy check

Commonly mistaken for alkaloids

Nitrogen-containing or “nootropic” does not automatically mean alkaloid. L-theanine is the most important correction for this shopping context. [1]

L-tyrosine

An amino acid—not an alkaloid.

5-HTP

An amino-acid derivative and serotonin precursor—not an alkaloid.

Taurine

An amino sulfonic acid—not an alkaloid.

Questions this directory should answer

References and regulatory sources

Primary research is used where available; federal and European public-health sources support taxonomy, regulation, and safety interpretation.

  1. [1] PubChem. L-Theanine compound summary. View source
  2. [2] U.S. Food and Drug Administration. FDA 101: Dietary Supplements. View source
  3. [3] U.S. Food and Drug Administration. Dietary supplement current good manufacturing practices. View source
  4. [4] NIH Office of Dietary Supplements. Dietary Supplements for Weight Loss: Health Professional Fact Sheet. View source
  5. [5] National Center for Complementary and Integrative Health. Bitter Orange: Usefulness and Safety. View source
  6. [6] National Center for Complementary and Integrative Health. Yohimbe: Usefulness and Safety. View source
  7. [7] Wang J, et al. The effects of Huperzine A on dementia and mild cognitive impairment: an overview of systematic reviews. 2021. View source
  8. [8] Schimpf M, et al. Toxicity From Blue Lotus After Ingestion or Inhalation: A Case Series. Military Medicine. 2023. View source
  9. [9] European Medicines Agency. Eschscholziae herba (California poppy) assessment resources. View source
  10. [10] U.S. Drug Enforcement Administration. Opium fact sheet (Papaver somniferum). View source
  11. [11] Eisenreich W, et al. Large variability in the alkaloid content of Corydalis yanhusuo dietary supplements. 2025. View source
  12. [12] National Center for Complementary and Integrative Health. Cat’s Claw: Usefulness and Safety. View source
  13. [13] National Center for Complementary and Integrative Health. Diabetes and Dietary Supplements (berberine evidence and safety). View source
  14. [14] U.S. Food and Drug Administration. Avoiding Products Contaminated with Hidden Ingredients. View source
  15. [15] U.S. Food and Drug Administration. Sexual Enhancement and Energy Product Notifications. View source

Editorial reading context

How to read Alkaloids on Amazon

A safety-first directory of naturally occurring alkaloids discussed in online supplement shopping, with evidence types, taxonomy checks, and product-screening criteria—not product endorsements. This guide is intended to help readers make sense of evidence, safety, and practical fit without turning supplement research into a one-size-fits-all checklist. Use it alongside the linked herb and compound profiles for deeper mechanism and safety details.

For Alkaloids on Amazon, focus on whether the evidence matches the exact outcome you care about, whether the dose discussed is realistic, and whether the safety profile fits your medical context. Strong marketing language should carry less weight than human evidence and transparent product quality.

When a page discusses dependence-forming substances, restricted compounds, or high-risk contexts, treat it as harm-reduction education only. It is not a buying guide, dosing instruction, or substitute for professional care.